Industry recognition. See more on the awards page.
At ICON, we are at the forefront of innovation in clinical research, harnessing the power of Artificial Intelligence to transform the way trials are conducted.
Our AI solutions are designed to accelerate trial timelines, improve data accuracy, optimise resource management, and ensure compliance—all while maintaining the highest ethical standards. With our AI-driven approach, we are committed to delivering faster, smarter, and more reliable outcomes that benefit sponsors, patients, and healthcare providers for a healthier world.
AI champions
Our AI literacy program and network of AI Champions identify areas for greater efficiencies within the organisation.
Data scientists and engineers
Data scientists and engineers drive robust strategies, testing, development and impactful solutions.
Award-winning solutions
Multi-award winning innovatiove and pragmatic solutions delivering measurable and impactful value to our clients.
Our AI solutions
To provide a comprehensive understanding of our AI capabilities, we ve categorised our solutions into three main areas.
Accelerating trial execution
Our solutions in this category focus on streamlining the clinical trial process, from site selection to patient enrolment and study startup. These tools significantly reduce trial timelines and improve overall trial performance.
One Search
Identify the right sites and investigators faster, reducing time to site identification and improving patient recruitment success rates.
ICONex
Quickly identify key opinion leaders in all therapeutic areas including rare diseases, accelerating study design and startup.
Cassandra
Predict post-marketing study requirements early, allowing for proactive planning and reducing the risk of regulatory delays.
Enhancing data and resource management
These solutions are designed to improve the quality and efficiency of data management and resource allocation, ensuring that clinical trials run smoothly and effectively.
SmartQuery
Leverage AI to automate clinical data management, reducing manual review time and improving data accuracy.
iSubmit
Automate document management for clinical trials, ensuring compliance and reducing the burden on study teams.
MRT COA
Stay updated with the latest clinical outcome assessments, providing comprehensive intelligence to optimise trial designs.
FORWARD+
Optimise your resource management with precise forecasting, targeted information and seamless automation.
Optimising operational efficiency
Our operational efficiency solutions are designed to transform the way teams interact with data and streamline critical processes, leading to faster and more informed decision making.
Study Startup Site Contracts
Use AI to streamline contract drafting, reducing negotiation cycles and accelerating site activation.
OMR AI Navigation Assistant
Gain quick, actionable insights from complex operational metrics with AI powered natural language queries.
Why Choose AI at ICON?
-
proven Results
Our AI solutions have been recognised with industry awards and have consistently delivered measurable improvements in trial performance. -
governance
We prioritise responsible AI use, backed by our AI Ethics Committee, ensuring that our solutions adhere to the highest standards of data privacy and security. -
innovation
We are continually pushing the boundaries of what's possible in clinical research to make trials more efficient, safe and insightful.
AI ethics committee
Our AI ethics committee ensures ICON is fully compliant and that we act ethically and with integrity. We will continue to provide the highest standard of data quality and protect and preserve our stakeholders’ individual privacy, confidentiality, and intellectual property rights.
-
Blog: Tested, tried and true: Why digital biomarkers are the AI & ML strategy pharma should prioritise
Rather than chasing generative AI, pharma executives can focus their AI & machine learning (ML) strategies for drug development on investing in and deploying connected sensors to reduce costs & improve patient outcomes.
-
Blog: Outcome measures: Driving precision health strategies forward
ICON has been speaking, collaborating, and building with top pharma throughout the year to help them develop better drugs, faster, for patients. Here are a few observations from this year.
-
Blog: Digital endpoints widely adopted in pharmaceutical and biotech-sponsored clinical trials
Over 130 pharma and biotech organizations have relied on AI-powered digital biomarkers and sensor-derived clinical outcome assessments (COAs) to capture patient-centered endpoints.
-
Blog: The impact of AI on the evolution of machine translation
From its nascent stages to the sophisticated systems we employ today, machine translation has become an indispensable efficiency generating tool.
-
Media article: Human-enabled AI driving enhancements in clinical trial site selection
In this piece from Clinical Trial Vanguard, Travis Caudill, Vice President, Feasibility, Site Identification & Clinical Informatics explores the improvements in site selection that human-enabled AI is delivering.
-
Blog: How human-enabled AI is creating a new map for navigating site selection
Discover how AI transforms site selection in clinical research by leveraging data and human expertise through an ecosystem approach to optimise site ranking, patient enrolment, and study timelines.
-
Blog: The rise and role of AI in medical imaging
Discover how AI is revolutionising medical imaging and clinical trials, enhancing efficiency, accuracy, and patient outcomes through innovative applications in oncology, cardiology and more.
-
Blog: How AI could transform literature surveillance for pharmacovigilance
In pharmacovigilance AI could be used to detect adverse events sooner, offering benefits for patients and researchers.
Get Started with AI at ICON
Ready to transform your clinical trials with AI? Contact us today to learn how ICON s AI solutions can accelerate your research and deliver better outcomes.